COVID-19 Impact on Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: CCD16A9AF684EN
QYResearch

Abstracts

This report focuses on the global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AMAG Pharmaceuticals Inc.
• Duchesnay Inc.
• Emotional Brain BV
• Novo Nordisk AS
• Sprout Pharmaceuticals Inc.
• ...

Market segment by Type, the product can be split into

• Non-hormonal Therapy
• Hormonal Therapy

Market segment by Application, split into

• Sexual Desire Disorders
• Sexual Arousal Disorders
• Orgasm Disorders
• Sexual Pain Disorders
• Post-orgasmic Diseases
• Pelvic Floor Dysfunction
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Female Sexual Dysfunction Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Female Sexual Dysfunction Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Female Sexual Dysfunction Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Female Sexual Dysfunction Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Non-hormonal Therapy
  1.4.3 Hormonal Therapy
1.5 Market by Application
  1.5.1 Global Female Sexual Dysfunction Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Sexual Desire Disorders
  1.5.3 Sexual Arousal Disorders
  1.5.4 Orgasm Disorders
  1.5.5 Sexual Pain Disorders
  1.5.6 Post-orgasmic Diseases
  1.5.7 Pelvic Floor Dysfunction
  1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Female Sexual Dysfunction Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Female Sexual Dysfunction Treatment Industry
    1.6.1.1 Female Sexual Dysfunction Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Female Sexual Dysfunction Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Female Sexual Dysfunction Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Female Sexual Dysfunction Treatment Market Perspective (2015-2026)
2.2 Female Sexual Dysfunction Treatment Growth Trends by Regions
  2.2.1 Female Sexual Dysfunction Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Female Sexual Dysfunction Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Female Sexual Dysfunction Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Female Sexual Dysfunction Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Female Sexual Dysfunction Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Female Sexual Dysfunction Treatment Players by Market Size
  3.1.1 Global Top Female Sexual Dysfunction Treatment Players by Revenue (2015-2020)
  3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Female Sexual Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Female Sexual Dysfunction Treatment Market Concentration Ratio
  3.2.1 Global Female Sexual Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Female Sexual Dysfunction Treatment Revenue in 2019
3.3 Female Sexual Dysfunction Treatment Key Players Head office and Area Served
3.4 Key Players Female Sexual Dysfunction Treatment Product Solution and Service
3.5 Date of Enter into Female Sexual Dysfunction Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Female Sexual Dysfunction Treatment Historic Market Size by Type (2015-2020)
4.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Type (2021-2026)

5 FEMALE SEXUAL DYSFUNCTION TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)
5.2 Global Female Sexual Dysfunction Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Female Sexual Dysfunction Treatment Market Size (2015-2020)
6.2 Female Sexual Dysfunction Treatment Key Players in North America (2019-2020)
6.3 North America Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
6.4 North America Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Female Sexual Dysfunction Treatment Market Size (2015-2020)
7.2 Female Sexual Dysfunction Treatment Key Players in Europe (2019-2020)
7.3 Europe Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
7.4 Europe Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Female Sexual Dysfunction Treatment Market Size (2015-2020)
8.2 Female Sexual Dysfunction Treatment Key Players in China (2019-2020)
8.3 China Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
8.4 China Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Female Sexual Dysfunction Treatment Market Size (2015-2020)
9.2 Female Sexual Dysfunction Treatment Key Players in Japan (2019-2020)
9.3 Japan Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
9.4 Japan Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Female Sexual Dysfunction Treatment Market Size (2015-2020)
10.2 Female Sexual Dysfunction Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Female Sexual Dysfunction Treatment Market Size (2015-2020)
11.2 Female Sexual Dysfunction Treatment Key Players in India (2019-2020)
11.3 India Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
11.4 India Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Female Sexual Dysfunction Treatment Market Size (2015-2020)
12.2 Female Sexual Dysfunction Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Female Sexual Dysfunction Treatment Market Size by Type (2015-2020)
12.4 Central & South America Female Sexual Dysfunction Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AMAG Pharmaceuticals Inc.
  13.1.1 AMAG Pharmaceuticals Inc. Company Details
  13.1.2 AMAG Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction
  13.1.4 AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020))
  13.1.5 AMAG Pharmaceuticals Inc. Recent Development
13.2 Duchesnay Inc.
  13.2.1 Duchesnay Inc. Company Details
  13.2.2 Duchesnay Inc. Business Overview and Its Total Revenue
  13.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Introduction
  13.2.4 Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020)
  13.2.5 Duchesnay Inc. Recent Development
13.3 Emotional Brain BV
  13.3.1 Emotional Brain BV Company Details
  13.3.2 Emotional Brain BV Business Overview and Its Total Revenue
  13.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Introduction
  13.3.4 Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2015-2020)
  13.3.5 Emotional Brain BV Recent Development
13.4 Novo Nordisk AS
  13.4.1 Novo Nordisk AS Company Details
  13.4.2 Novo Nordisk AS Business Overview and Its Total Revenue
  13.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Introduction
  13.4.4 Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2015-2020)
  13.4.5 Novo Nordisk AS Recent Development
13.5 Sprout Pharmaceuticals Inc.
  13.5.1 Sprout Pharmaceuticals Inc. Company Details
  13.5.2 Sprout Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Introduction
  13.5.4 Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020)
  13.5.5 Sprout Pharmaceuticals Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Female Sexual Dysfunction Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Female Sexual Dysfunction Treatment Revenue
Table 3. Ranking of Global Top Female Sexual Dysfunction Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-hormonal Therapy
Table 6. Key Players of Hormonal Therapy
Table 7. COVID-19 Impact Global Market: (Four Female Sexual Dysfunction Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Female Sexual Dysfunction Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Female Sexual Dysfunction Treatment Players to Combat Covid-19 Impact
Table 12. Global Female Sexual Dysfunction Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Female Sexual Dysfunction Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Female Sexual Dysfunction Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Female Sexual Dysfunction Treatment Market Share by Regions (2015-2020)
Table 16. Global Female Sexual Dysfunction Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Female Sexual Dysfunction Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Female Sexual Dysfunction Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Female Sexual Dysfunction Treatment Players
Table 23. Global Female Sexual Dysfunction Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Female Sexual Dysfunction Treatment Market Share by Players (2015-2020)
Table 25. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Sexual Dysfunction Treatment as of 2019)
Table 26. Global Female Sexual Dysfunction Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Female Sexual Dysfunction Treatment Product Solution and Service
Table 29. Date of Enter into Female Sexual Dysfunction Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Female Sexual Dysfunction Treatment Market Size Share by Type (2015-2020)
Table 33. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Female Sexual Dysfunction Treatment Market Size Share by Application (2015-2020)
Table 35. Global Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Female Sexual Dysfunction Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 39. North America Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 41. North America Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 45. Europe Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 47. Europe Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 51. China Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 53. China Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 57. Japan Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 59. Japan Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 63. Southeast Asia Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 69. India Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 71. India Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Female Sexual Dysfunction Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Female Sexual Dysfunction Treatment Market Share (2019-2020)
Table 75. Central & South America Female Sexual Dysfunction Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Female Sexual Dysfunction Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Female Sexual Dysfunction Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Female Sexual Dysfunction Treatment Market Share by Application (2015-2020)
Table 79. AMAG Pharmaceuticals Inc. Company Details
Table 80. AMAG Pharmaceuticals Inc. Business Overview
Table 81. AMAG Pharmaceuticals Inc. Product
Table 82. AMAG Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020) (Million US$)
Table 83. AMAG Pharmaceuticals Inc. Recent Development
Table 84. Duchesnay Inc. Company Details
Table 85. Duchesnay Inc. Business Overview
Table 86. Duchesnay Inc. Product
Table 87. Duchesnay Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020) (Million US$)
Table 88. Duchesnay Inc. Recent Development
Table 89. Emotional Brain BV Company Details
Table 90. Emotional Brain BV Business Overview
Table 91. Emotional Brain BV Product
Table 92. Emotional Brain BV Revenue in Female Sexual Dysfunction Treatment Business (2015-2020) (Million US$)
Table 93. Emotional Brain BV Recent Development
Table 94. Novo Nordisk AS Company Details
Table 95. Novo Nordisk AS Business Overview
Table 96. Novo Nordisk AS Product
Table 97. Novo Nordisk AS Revenue in Female Sexual Dysfunction Treatment Business (2015-2020) (Million US$)
Table 98. Novo Nordisk AS Recent Development
Table 99. Sprout Pharmaceuticals Inc. Company Details
Table 100. Sprout Pharmaceuticals Inc. Business Overview
Table 101. Sprout Pharmaceuticals Inc. Product
Table 102. Sprout Pharmaceuticals Inc. Revenue in Female Sexual Dysfunction Treatment Business (2015-2020) (Million US$)
Table 103. Sprout Pharmaceuticals Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Female Sexual Dysfunction Treatment Market Share by Type: 2020 VS 2026
Figure 2. Non-hormonal Therapy Features
Figure 3. Hormonal Therapy Features
Figure 4. Global Female Sexual Dysfunction Treatment Market Share by Application: 2020 VS 2026
Figure 5. Sexual Desire Disorders Case Studies
Figure 6. Sexual Arousal Disorders Case Studies
Figure 7. Orgasm Disorders Case Studies
Figure 8. Sexual Pain Disorders Case Studies
Figure 9. Post-orgasmic Diseases Case Studies
Figure 10. Pelvic Floor Dysfunction Case Studies
Figure 11. Other Case Studies
Figure 12. Female Sexual Dysfunction Treatment Report Years Considered
Figure 13. Global Female Sexual Dysfunction Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Female Sexual Dysfunction Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Female Sexual Dysfunction Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Female Sexual Dysfunction Treatment Market Share by Players in 2019
Figure 18. Global Top Female Sexual Dysfunction Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Sexual Dysfunction Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Female Sexual Dysfunction Treatment Revenue in 2019
Figure 20. North America Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Female Sexual Dysfunction Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. AMAG Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AMAG Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2015-2020)
Figure 29. Duchesnay Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Duchesnay Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2015-2020)
Figure 31. Emotional Brain BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Emotional Brain BV Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2015-2020)
Figure 33. Novo Nordisk AS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novo Nordisk AS Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2015-2020)
Figure 35. Sprout Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sprout Pharmaceuticals Inc. Revenue Growth Rate in Female Sexual Dysfunction Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed